Theranica Company

Theranica is the developer of Nerivio, a fully integrated, self-contained family of therapeutic patches. The patches and other types of wearables in the company’s pipeline are controlled by smartphone applications to easily adapt therapy treatments to everyday life.

Theranica’s Nerivio Migra is a migraine-relief patch that provides migraine treatment through neuromodulation. Instead of placing electrodes on their head, patients can attach Theranica’s clinically tested, wearable patch to their arm and launch a personalized pain-relief program.
Technology: Diagnostics and consultation
Industry: General Healthcare
Headquarters: Netanya, HaMerkaz, Israel
Founded Date: 01-01-2016
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 8
Total Funding: $86,000,000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-08-29
Last Funding Type: Series C

Visit Website
nfo@theranica.com
https://twitter.com/theranica
Register and Claim Ownership